sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Pharmaceuticals / Pharmacovigilance

Pharmacovigilance Market By Service Provider (In-house, and Contract Outsourcing), By Product Life Cycle (Pre-clinical, Phase I, Phase II, Phase III, and Phase IV), By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining), By Process Flow (Case Data Management, Signal Detection, and Risk Management System), By Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, and Others), and By End user (Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, and Others)Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

  • Publish On: Mar-2021
  • Total Pages: 225
  • Report Code: FAF-1407
  • Base Year: 2020
  • Format:

Industry Insights

[225+ Pages Report] Global Pharmacovigilance market was projected at USD 5.68 Billion in 2019, which is expected to hit USD 12.38 Billion in 2026 and is expected to rise to CAGR by 11.5% between 2020 and 2026.

Global Pharmacovigilance Market: Overview

Patient treatment and wellbeing with regards to the use of drugs are the main focus of the Pharmacovigilance PV sector. It also promotes public health programs, through the provision of accurate and balanced information for the proper evaluation of drugs' harmful consequences. The PV industry includes a number of tasks such as the identification, monitoring, and analysis of adverse drug reactions in the production of the requisite data points for regulatory activities. In addition, increased patient population use of medications combined with increased drug safety standards is the key contributor to growth in the photovoltaics industry in the coming few years. In terms of sales and growth, PV outsourcing gains traction because of progress in PV technologies and services. A world economy has been paved with the existence of a forum for information technology. Moreover, in order to invent new vaccines that have launched many clinical trials, the advent of COVID-19 has opened up several possibilities for pharmaceutical firms The photovoltaics market is also opened because it is the main step in any process of drugs production.

Global Pharmacovigilance Market: Growth Factors

Security and feasibility are the two key criteria that must be passed during any step of the clinical trial. Populations today are more mindful of the side effects of OTC drugs and thus require safer prescriptions. The monitoring of branded drugs for potential ADRs would certainly improve this market benefit. In addition, government policies, and awareness programs for pharmaceutical firms have a larger influence on the dissemination of accurate medicinal knowledge, the safe use of medicinal drugs, the side effects of medicinal products, etc. The Uppsala Monitoring Center (UMC), for example, operates a social media program every year to enable patients and the general population to be aware of the proper use of drugs and update on suspicious ADRs. In 2019, UMC initiated a program aimed at pharmaceutical production and the healthy use of drugs for seniors. These good policies are also likely during the projected period to encourage development and growth in this sector. The current competition in Pharmacovigilance offers an option to outsource the PV operation for pharmaceutical products and hospitals in the context of time limitations and services that an outsourced operation can provide; PV outsourcing has optimum benefits for production firms. Outsourcing also enables businesses to be customized to their needs, thereby increasing the tempo of the assessment process. Due to the benefits of outsourcing services, the market for these services is growing and numerous outsourcing opportunities for providers have been created. These providers concentrate on expanding their business portfolio in order to provide consumers with more advanced solutions. Growing demand for outsourcing at a minimum cost thus leads to the advent of new players on this market, which accelerates market growth from 2020 to late 2026.

Global Pharmacovigilance Market: Segmentation

Based on service provider market is sub-segmented into contract outsourcing, and in-house. Based on the product life cycle market is divided into phase II, Phase I, Phase III, Phase IV, and Pre-clinical. Based on type market is divided into targeted spontaneous reporting, intensified ADR reporting, EHR mining, spontaneous reporting, and cohort event monitoring. Based on process flow the market is divided into signal detection, risk management system, and case data management. Based on therapeutic area market is divided into oncology, respiratory systems, cardiology, neurology, and others. Based on end-users the market is further divided into pharmaceutical, medical device manufacturers, biotechnology companies, and others.

Global Pharmacovigilance Market: Regional Analysis

On the regional front, the pharmacovigilance market is classified into North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Because of the largest number of PV operations in the country, North America leads this market share. The vast number of deaths caused by ADRs leading to the stringent need for PV was combined with this. In addition, the area has well-established PV centers for the management of its operations with advanced tools. The emphasis on the risk management of pharmaceutical drugs makes Europe the second-largest consumer place. Various tracking programs have been developed in the country, including the European Medicines Agency, EudraVigilance, and others to access and control ADRs.

Global Pharmacovigilance Market: Competitive Players

Some of the key players in the Pharmacovigilance Market are Wipro Ltd, United BioSource Corporation, PAREXEL International Corporation, TAKE Solutions Ltd., Linical Accelovance, ITClinical, IQVIA, ICON PLC, IBM Corporation, Foresight Group International AG, FMD K&L Inc., Cognizant, Capgemini, BioClinica, ArisGlobal, Accenture, and Others.

Global Pharmacovigilance Market: Regional Segment Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • The Middle East and Africa

KEY REPORT POINTERS & HIGHLIGHTS:

  • Statistically Validated Analysis of Historical, Current, and Projected Industry Trends with Authenticated Market Sizes Information and Data in terms of Value and Volume, wherever applicable
  • Direct and Indirect Factors that Impacted the Industry as well Projected Rationales expected to affect the industry going forward
  • Micro, Meso, Macro, and In-Depth Analysis of Technically relevant and Commercially viable Segments and Sub-segments of the Market
  • Historical and Projected Company / Vendor / OEM / Supplier Market Shares, Competitive Landscape, and Player Positioning Data
  • Historical and Current Demand (Consumption) and Supply (Production) Scenarios as well as Projected Supply-Demand Scenario Analysis
  • Detailed List of Key Buyers and End-Users (Consumers) analyzed as per Regions and Applications
  • Value Chain and Supply Chain Analysis along with Horizontal and Vertical Integration Scenarios
  • Manufacturing and Production Cost Structure Analysis including Labor Cost, Raw Material Expenses, and Other Manufacturing Expenses, wherever relevant
  • Overview of Key Marketing Strategies and Key Sales Channels Adopted in the Market
  • Market Attractiveness Analysis and Key Investment Opportunity Analysis in the Market going forward
  • Technological Roadmap, Patents Analysis, Potential Substitutes, and Technical Analysis
  • The professionally substantiated market research report study is calculated, constructed, and assembled by implementing a Robust Research Methodology. The Triangular Process comprises a buoyant mix of Exhaustive Primary Research (focused interviews, questionnaires, and ad-hoc surveys) and Extended Secondary Research (paid external databases, proprietary in-house database, and publically-available validated sources), where it is finally triangulated and validated through in-house industry experts, industry leaders, and independent consultants through a tri-level quality check practice.

Table of Content

  1. Chapter 1 Executive Summary
    1. 1.1. Introduction of Pharmacovigilance
    2. 1.2. Global Pharmacovigilance Market, 2019 & 2026 (USD Million)
    3. 1.3. COVID-19 Impacts on Pharmacovigilance Market
      1. 1.3.1. Short Term COVID-19 Impact on the Market
      2. 1.3.2. Mid-Term COVID-19 Impact on the Market
      3. 1.3.3. Long-Term COVID-19 Impact on the Market
    4. 1.4. Business Strategies and Recommendations
    5. 1.5. Global Pharmacovigilance Market, 2016 – 2026 (USD Million)
    6. 1.6. Global Pharmacovigilance Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
    7. 1.7. Global Pharmacovigilance Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
  2. Chapter 2 Pharmacovigilance Market – Service Provider Analysis
    1. 2.1. Global Pharmacovigilance Market – Service Provider Overview
    2. 2.2. Global Pharmacovigilance Market Share, by Service Provider, 2019 & 2026 (USD Million)
    3. 2.3. In-house
      1. 2.3.1. Global In-house Pharmacovigilance Market, 2016 – 2026 (USD Million)
    4. 2.4. Contract Outsourcing
      1. 2.4.1. Global Contract Outsourcing Pharmacovigilance Market, 2016 – 2026 (USD Million)
  3. Chapter 3 Pharmacovigilance Market – Product Life Cycle Analysis
    1. 3.1. Global Pharmacovigilance Market – Product Life Cycle Overview
    2. 3.2. Global Pharmacovigilance Market Share, by Product Life Cycle, 2019 & 2026 (USD Million)
    3. 3.3. Pre-clinical
      1. 3.3.1. Global Pre-clinical Pharmacovigilance Market, 2016 – 2026 (USD Million)
    4. 3.4. Phase I
      1. 3.4.1. Global Phase I Pharmacovigilance Market, 2016 – 2026 (USD Million)
    5. 3.5. Phase II
      1. 3.5.1. Global Phase II Pharmacovigilance Market, 2016 – 2026 (USD Million)
    6. 3.6. Phase III
      1. 3.6.1. Global Phase III Pharmacovigilance Market, 2016 – 2026 (USD Million)
    7. 3.7. Phase IV
      1. 3.7.1. Global Phase IV Pharmacovigilance Market, 2016 – 2026 (USD Million)
  4. Chapter 4 Pharmacovigilance Market – Type Analysis
    1. 4.1. Global Pharmacovigilance Market – Type Overview
    2. 4.2. Global Pharmacovigilance Market Share, by Type, 2019 & 2026 (USD Million)
    3. 4.3. Spontaneous Reporting
      1. 4.3.1. Global Spontaneous Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
    4. 4.4. Intensified ADR Reporting
      1. 4.4.1. Global Intensified ADR Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
    5. 4.5. Targeted Spontaneous Reporting
      1. 4.5.1. Global Targeted Spontaneous Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
    6. 4.6. Cohort Event Monitoring
      1. 4.6.1. Global Cohort Event Monitoring Pharmacovigilance Market, 2016 – 2026 (USD Million)
    7. 4.7. EHR Mining
      1. 4.7.1. Global EHR Mining Pharmacovigilance Market, 2016 – 2026 (USD Million)
  5. Chapter 5 Pharmacovigilance Market – Process Flow Analysis
    1. 5.1. Global Pharmacovigilance Market – Process Flow Overview
    2. 5.2. Global Pharmacovigilance Market Share, by Process Flow, 2019 & 2026 (USD Million)
    3. 5.3. Case Data Management
      1. 5.3.1. Global Case Data Management Pharmacovigilance Market, 2016 – 2026 (USD Million)
    4. 5.4. Signal Detection
      1. 5.4.1. Global Signal Detection Pharmacovigilance Market, 2016 – 2026 (USD Million)
    5. 5.5. Risk Management System
      1. 5.5.1. Global Risk Management System Pharmacovigilance Market, 2016 – 2026 (USD Million)
  6. Chapter 6 Pharmacovigilance Market – Therapeutic Area Analysis
    1. 6.1. Global Pharmacovigilance Market – Therapeutic Area Overview
    2. 6.2. Global Pharmacovigilance Market Share, by Therapeutic Area, 2019 & 2026 (USD Million)
    3. 6.3. Oncology
      1. 6.3.1. Global Oncology Pharmacovigilance Market, 2016 – 2026 (USD Million)
    4. 6.4. Neurology
      1. 6.4.1. Global Neurology Pharmacovigilance Market, 2016 – 2026 (USD Million)
    5. 6.5. Cardiology
      1. 6.5.1. Global Cardiology Pharmacovigilance Market, 2016 – 2026 (USD Million)
    6. 6.6. Respiratory Systems
      1. 6.6.1. Global Respiratory Systems Pharmacovigilance Market, 2016 – 2026 (USD Million)
    7. 6.7. Others
      1. 6.7.1. Global Others Pharmacovigilance Market, 2016 – 2026 (USD Million)
  7. Chapter 7 Pharmacovigilance Market – End user Analysis
    1. 7.1. Global Pharmacovigilance Market – End user Overview
    2. 7.2. Global Pharmacovigilance Market Share, by End user, 2019 & 2026 (USD Million)
    3. 7.3. Pharmaceuticals
      1. 7.3.1. Global Pharmaceuticals Pharmacovigilance Market, 2016 – 2026 (USD Million)
    4. 7.4. Biotechnology Companies
      1. 7.4.1. Global Biotechnology Companies Pharmacovigilance Market, 2016 – 2026 (USD Million)
    5. 7.5. Medical Device Manufacturers
      1. 7.5.1. Global Medical Device Manufacturers Pharmacovigilance Market, 2016 – 2026 (USD Million)
    6. 7.6. Others
      1. 7.6.1. Global Others Pharmacovigilance Market, 2016 – 2026 (USD Million)
  8. Chapter 8 Pharmacovigilance Market – Regional Analysis
    1. 8.1. Global Pharmacovigilance Market Regional Overview
    2. 8.2. Global Pharmacovigilance Market Share, by Region, 2019 & 2026 (USD Million)
    3. 8.3. North America
      1. 8.3.1. North America Pharmacovigilance Market, 2016 – 2026 (USD Million)
      2. 8.3.2. North America Pharmacovigilance Market, by Service Provider, 2016 – 2026
      3. 8.3.3. North America Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026
      4. 8.3.4. North America Pharmacovigilance Market, by Type, 2016 – 2026
      5. 8.3.5. North America Pharmacovigilance Market, by Process Flow, 2016 – 2026
      6. 8.3.6. North America Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026
      7. 8.3.7. North America Pharmacovigilance Market, by End user, 2016 – 2026
      8. 8.3.8. U.S.
      9. 8.3.9. Canada
    4. 8.4. Europe
      1. 8.4.1. Europe Pharmacovigilance Market, 2016 – 2026 (USD Million)
      2. 8.4.2. Europe Pharmacovigilance Market, by Service Provider, 2016 – 2026
      3. 8.4.3. Europe Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026
      4. 8.4.4. Europe Pharmacovigilance Market, by Type, 2016 – 2026
      5. 8.4.5. Europe Pharmacovigilance Market, by Process Flow, 2016 – 2026
      6. 8.4.6. Europe Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026
      7. 8.4.7. Europe Pharmacovigilance Market, by End user, 2016 – 2026
      8. 8.4.8. Germany
      9. 8.4.9. France
      10. 8.4.10. U.K.
      11. 8.4.11. Italy
      12. 8.4.12. Spain
      13. 8.4.13. Rest of Europe
    5. 8.5. Asia Pacific
      1. 8.5.1. Asia Pacific Pharmacovigilance Market, 2016 – 2026 (USD Million)
      2. 8.5.2. Asia Pacific Pharmacovigilance Market, by Service Provider, 2016 – 2026
      3. 8.5.3. Asia Pacific Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026
      4. 8.5.4. Asia Pacific Pharmacovigilance Market, by Type, 2016 – 2026
      5. 8.5.5. Asia Pacific Pharmacovigilance Market, by Process Flow, 2016 – 2026
      6. 8.5.6. Asia Pacific Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026
      7. 8.5.7. Asia Pacific Pharmacovigilance Market, by End user, 2016 – 2026
      8. 8.5.8. China
      9. 8.5.9. Japan
      10. 8.5.10. India
      11. 8.5.11. SouthKorea
      12. 8.5.12. South-East Asia
      13. 8.5.13. Rest of Asia Pacific
    6. 8.6. Latin America
      1. 8.6.1. Latin America Pharmacovigilance Market, 2016 – 2026 (USD Million)
      2. 8.6.2. Latin America Pharmacovigilance Market, by Service Provider, 2016 – 2026
      3. 8.6.3. Latin America Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026
      4. 8.6.4. Latin America Pharmacovigilance Market, by Type, 2016 – 2026
      5. 8.6.5. Latin America Pharmacovigilance Market, by Process Flow, 2016 – 2026
      6. 8.6.6. Latin America Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026
      7. 8.6.7. Latin America Pharmacovigilance Market, by End user, 2016 – 2026
      8. 8.6.8. Brazil
      9. 8.6.9. Mexico
      10. 8.6.10. Rest of Latin America
    7. 8.7. The Middle-East and Africa
      1. 8.7.1. The Middle-East and Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
      2. 8.7.2. The Middle-East and Africa Pharmacovigilance Market, by Service Provider, 2016 – 2026
      3. 8.7.3. The Middle-East and Africa Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026
      4. 8.7.4. The Middle-East and Africa Pharmacovigilance Market, by Type, 2016 – 2026
      5. 8.7.5. The Middle-East and Africa Pharmacovigilance Market, by Process Flow, 2016 – 2026
      6. 8.7.6. The Middle-East and Africa Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026
      7. 8.7.7. The Middle-East and Africa Pharmacovigilance Market, by End user, 2016 – 2026
      8. 8.7.8. GCC Countries
      9. 8.7.9. South Africa
      10. 8.7.10. Rest of Middle-East Africa
  9. Chapter 9 Pharmacovigilance Market – Competitive Landscape
    1. 9.1. Competitor Market Share – Revenue
    2. 9.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 9.3. Strategic Developments
      1. 9.3.1. Acquisitions and Mergers
      2. 9.3.2. New Products
      3. 9.3.3. Research & Development Activities
  10. Chapter 10 Company Profiles
    1. 10.1. Wipro Ltd
      1. 10.1.1. Company Overview
      2. 10.1.2. Product/Service Portfolio
      3. 10.1.3. Wipro Ltd Sales, Revenue, and Gross Margin
      4. 10.1.4. Wipro Ltd Revenue and Growth Rate
      5. 10.1.5. Wipro Ltd Market Share
      6. 10.1.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    2. 10.2. United BioSource Corporation
      1. 10.2.1. Company Overview
      2. 10.2.2. Product/Service Portfolio
      3. 10.2.3. United BioSource Corporation Sales, Revenue, and Gross Margin
      4. 10.2.4. United BioSource Corporation Revenue and Growth Rate
      5. 10.2.5. United BioSource Corporation Market Share
      6. 10.2.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    3. 10.3. TAKE Solutions Ltd.
      1. 10.3.1. Company Overview
      2. 10.3.2. Product/Service Portfolio
      3. 10.3.3. TAKE Solutions Ltd. Sales, Revenue, and Gross Margin
      4. 10.3.4. TAKE Solutions Ltd. Revenue and Growth Rate
      5. 10.3.5. TAKE Solutions Ltd. Market Share
      6. 10.3.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    4. 10.4. PAREXEL International Corporation
      1. 10.4.1. Company Overview
      2. 10.4.2. Product/Service Portfolio
      3. 10.4.3. PAREXEL International Corporation Sales, Revenue, and Gross Margin
      4. 10.4.4. PAREXEL International Corporation Revenue and Growth Rate
      5. 10.4.5. PAREXEL International Corporation Market Share
      6. 10.4.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    5. 10.5. Linical Accelovance
      1. 10.5.1. Company Overview
      2. 10.5.2. Product/Service Portfolio
      3. 10.5.3. Linical Accelovance Sales, Revenue, and Gross Margin
      4. 10.5.4. Linical Accelovance Revenue and Growth Rate
      5. 10.5.5. Linical Accelovance Market Share
      6. 10.5.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    6. 10.6. Laboratory Corporation of America Holdings
      1. 10.6.1. Company Overview
      2. 10.6.2. Product/Service Portfolio
      3. 10.6.3. Laboratory Corporation of America Holdings Sales, Revenue, and Gross Margin
      4. 10.6.4. Laboratory Corporation of America Holdings Revenue and Growth Rate
      5. 10.6.5. Laboratory Corporation of America Holdings Market Share
      6. 10.6.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    7. 10.7. ITClinical
      1. 10.7.1. Company Overview
      2. 10.7.2. Product/Service Portfolio
      3. 10.7.3. ITClinical Sales, Revenue, and Gross Margin
      4. 10.7.4. ITClinical Revenue and Growth Rate
      5. 10.7.5. ITClinical Market Share
      6. 10.7.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    8. 10.8. IQVIA
      1. 10.8.1. Company Overview
      2. 10.8.2. Product/Service Portfolio
      3. 10.8.3. IQVIA Sales, Revenue, and Gross Margin
      4. 10.8.4. IQVIA Revenue and Growth Rate
      5. 10.8.5. IQVIA Market Share
      6. 10.8.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    9. 10.9. ICON PLC
      1. 10.9.1. Company Overview
      2. 10.9.2. Product/Service Portfolio
      3. 10.9.3. ICON PLC Sales, Revenue, and Gross Margin
      4. 10.9.4. ICON PLC Revenue and Growth Rate
      5. 10.9.5. ICON PLC Market Share
      6. 10.9.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    10. 10.10. IBM Corporation
      1. 10.10.1. Company Overview
      2. 10.10.2. Product/Service Portfolio
      3. 10.10.3. IBM Corporation Sales, Revenue, and Gross Margin
      4. 10.10.4. IBM Corporation Revenue and Growth Rate
      5. 10.10.5. IBM Corporation Market Share
      6. 10.10.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    11. 10.11. Foresight Group International AG
      1. 10.11.1. Company Overview
      2. 10.11.2. Product/Service Portfolio
      3. 10.11.3. Foresight Group International AG Sales, Revenue, and Gross Margin
      4. 10.11.4. Foresight Group International AG Revenue and Growth Rate
      5. 10.11.5. Foresight Group International AG Market Share
      6. 10.11.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    12. 10.12. FMD K&L Inc.
      1. 10.12.1. Company Overview
      2. 10.12.2. Product/Service Portfolio
      3. 10.12.3. FMD K&L Inc. Sales, Revenue, and Gross Margin
      4. 10.12.4. FMD K&L Inc. Revenue and Growth Rate
      5. 10.12.5. FMD K&L Inc. Market Share
      6. 10.12.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    13. 10.13. Cognizant
      1. 10.13.1. Company Overview
      2. 10.13.2. Product/Service Portfolio
      3. 10.13.3. Cognizant Sales, Revenue, and Gross Margin
      4. 10.13.4. Cognizant Revenue and Growth Rate
      5. 10.13.5. Cognizant Market Share
      6. 10.13.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    14. 10.14. Capgemini
      1. 10.14.1. Company Overview
      2. 10.14.2. Product/Service Portfolio
      3. 10.14.3. Capgemini Sales, Revenue, and Gross Margin
      4. 10.14.4. Capgemini Revenue and Growth Rate
      5. 10.14.5. Capgemini Market Share
      6. 10.14.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    15. 10.15. BioClinica
      1. 10.15.1. Company Overview
      2. 10.15.2. Product/Service Portfolio
      3. 10.15.3. BioClinica Sales, Revenue, and Gross Margin
      4. 10.15.4. BioClinica Revenue and Growth Rate
      5. 10.15.5. BioClinica Market Share
      6. 10.15.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    16. 10.16. ArisGlobal
      1. 10.16.1. Company Overview
      2. 10.16.2. Product/Service Portfolio
      3. 10.16.3. ArisGlobal Sales, Revenue, and Gross Margin
      4. 10.16.4. ArisGlobal Revenue and Growth Rate
      5. 10.16.5. ArisGlobal Market Share
      6. 10.16.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
    17. 10.17. Accenture
      1. 10.17.1. Company Overview
      2. 10.17.2. Product/Service Portfolio
      3. 10.17.3. Accenture Sales, Revenue, and Gross Margin
      4. 10.17.4. Accenture Revenue and Growth Rate
      5. 10.17.5. Accenture Market Share
      6. 10.17.6. Recent Initiatives, Funding/VC Activities, and Technological Innovations
  11. Chapter 11 Pharmacovigilance — Industry Analysis
    1. 11.1. Introduction and Taxonomy
    2. 11.2. Pharmacovigilance Market – Key Trends
      1. 11.2.1. Market Drivers
      2. 11.2.2. Market Restraints
      3. 11.2.3. Market Opportunities
    3. 11.3. Value Chain Analysis
    4. 11.4. Key Mandates and Regulations
    5. 11.5. Technology Roadmap and Timeline
    6. 11.6. Pharmacovigilance Market – Attractiveness Analysis
      1. 11.6.1. By Service Provider
      2. 11.6.2. By Product Life Cycle
      3. 11.6.3. By Type
      4. 11.6.4. By Process Flow
      5. 11.6.5. By Therapeutic Area
      6. 11.6.6. By End user
      7. 11.6.7. By Region
  12. Chapter 12 Industrial Chain, Sourcing Strategy, and Downstream Buyers
    1. 12.1. Pharmacovigilance Industrial Chain Analysis
    2. 12.2. Downstream Buyers
    3. 12.3. Distributors/Traders List
  13. Chapter 13 Marketing Strategy Analysis
    1. 13.1. Marketing Channel
    2. 13.2. Direct Marketing
    3. 13.3. Indirect Marketing
    4. 13.4. Marketing Channel Development Trends
    5. 13.5. Economic/Political Environmental Change
  14. Chapter 14 Report Conclusion & Key Insights
    1. 14.1. Key Insights from Primary Interviews & Surveys Respondents
    2. 14.2. Key Takeaways from Analysts, Consultants, and Industry Leaders
  15. Chapter 15 Research Approach & Methodology
    1. 15.1. Report Description
    2. 15.2. Research Scope
    3. 15.3. Research Methodology
      1. 15.3.1. Secondary Research
      2. 15.3.2. Primary Research
      3. 15.3.3. Statistical Models
      4. 15.3.4. Research Limitations

      List of Figures

      Fig.1	Product Picture of Pharmacovigilance
      Fig.2	Global Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.3	Global Pharmacovigilance Market Absolute Revenue Opportunity, 2016 – 2026 (USD Million)
      Fig.4	Global Pharmacovigilance Market Incremental Revenue Opportunity, 2020 – 2026 (USD Million)
      Fig.5	Global Pharmacovigilance Market Share, by Service Provider, 2019 & 2026 (USD Million)
      Fig.6	Global In-house Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.7	Global Contract Outsourcing Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.8	Global Pharmacovigilance Market Share, by Product Life Cycle, 2019 & 2026 (USD Million)
      Fig.9	Global Pre-clinical Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.10	Global Phase I Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.11	Global Phase II Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.12	Global Phase III Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.13	Global Phase IV Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.14	Global Pharmacovigilance Market Share, by Type, 2019 & 2026 (USD Million)
      Fig.15	Global Spontaneous Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.16	Global Intensified ADR Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.17	Global Targeted Spontaneous Reporting Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.18	Global Cohort Event Monitoring Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.19	Global EHR Mining Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.20	Global Pharmacovigilance Market Share, by Process Flow, 2019 & 2026 (USD Million)
      Fig.21	Global Case Data Management Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.22	Global Signal Detection Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.23	Global Risk Management System Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.24	Global Pharmacovigilance Market Share, by Therapeutic Area, 2019 & 2026 (USD Million)
      Fig.25	Global Oncology Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.26	Global Neurology Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.27	Global Cardiology Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.28	Global Respiratory Systems Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.29	Global Others Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.30	Global Pharmacovigilance Market Share, by End user, 2019 & 2026 (USD Million)
      Fig.31	Global Pharmaceuticals Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.32	Global Biotechnology Companies Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.33	Global Medical Device Manufacturers Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.34	Global Others Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.35	Global Pharmacovigilance Market Share, by Region, 2019 & 2026 (USD Million)
      Fig.36	North America Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.37	U.S. Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.38	Canada Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.39	Europe Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.40	Germany Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.41	France Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.42	U.K. Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.43	Italy Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.44	Spain Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.45	Rest of Europe Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.46	Asia Pacific Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.47	China Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.48	Japan Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.49	India Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.50	South Korea Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.51	South-East Asia Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.52	Rest of Asia Pacific Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.53	Latin America Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.54	Brazil Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.55	Mexico Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.56	Rest of Latin America Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.57	The Middle-East and Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.58	GCC Countries Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.59	South Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.60	Rest of Middle-East Africa Pharmacovigilance Market, 2016 – 2026 (USD Million)
      Fig.61	Competitor Market Share – Revenue
      Fig.62	Wipro Ltd Revenue and Growth Rate
      Fig.63	Wipro Ltd Market Share
      Fig.64	United BioSource Corporation Revenue and Growth Rate
      Fig.65	United BioSource Corporation Market Share
      Fig.66	TAKE Solutions Ltd. Revenue and Growth Rate
      Fig.67	TAKE Solutions Ltd. Market Share
      Fig.68	PAREXEL International Corporation Revenue and Growth Rate
      Fig.69	PAREXEL International Corporation Market Share
      Fig.70	Linical Accelovance Revenue and Growth Rate
      Fig.71	Linical Accelovance Market Share
      Fig.72	Laboratory Corporation of America Holdings Revenue and Growth Rate
      Fig.73	Laboratory Corporation of America Holdings Market Share
      Fig.74	ITClinical Revenue and Growth Rate
      Fig.75	ITClinical Market Share
      Fig.76	IQVIA Revenue and Growth Rate
      Fig.77	IQVIA Market Share
      Fig.78	ICON PLC Revenue and Growth Rate
      Fig.79	ICON PLC Market Share
      Fig.80	IBM Corporation Revenue and Growth Rate
      Fig.81	IBM Corporation Market Share
      Fig.82	Foresight Group International AG Revenue and Growth Rate
      Fig.83	Foresight Group International AG Market Share
      Fig.84	FMD K&L Inc. Revenue and Growth Rate
      Fig.85	FMD K&L Inc. Market Share
      Fig.86	Cognizant Revenue and Growth Rate
      Fig.87	Cognizant Market Share
      Fig.88	Capgemini Revenue and Growth Rate
      Fig.89	Capgemini Market Share
      Fig.90	BioClinica Revenue and Growth Rate
      Fig.91	BioClinica Market Share
      Fig.92	ArisGlobal Revenue and Growth Rate
      Fig.93	ArisGlobal Market Share
      Fig.94	Accenture Revenue and Growth Rate
      Fig.95	Accenture Market Share
      Fig.96	Market Dynamics
      Fig.97	Global Pharmacovigilance – Value Chain Analysis
      Fig.98	Key Mandates and Regulations
      Fig.99	Technology Roadmap and Timeline
      Fig.100	Market Attractiveness Analysis – By Service Provider
      Fig.101	Market Attractiveness Analysis – By Product Life Cycle
      Fig.102	Market Attractiveness Analysis – By Type
      Fig.103	Market Attractiveness Analysis – By Process Flow
      Fig.104	Market Attractiveness Analysis – By Therapeutic Area
      Fig.105	Market Attractiveness Analysis – By End user
      Fig.106	Market Attractiveness Analysis – By Region
      Fig.107	Pharmacovigilance Industrial Chain Analysis
      Fig.108	Market Channels
      Fig.109	Marketing Channel Development Trend
      Fig.110	Growth in World Gross Product, 2008-2018
      

      List of Tables

      Table 1 Global Pharmacovigilance Market, 2019 & 2026 (USD Million)
      Table 2 Global Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
      Table 3 Global Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
      Table 4 Global Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
      Table 5 Global Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
      Table 6 Global Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 7 Global Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
      Table 8 Global Pharmacovigilance Market, by Region, 2016 – 2026 (USD Million)
      Table 9 North America Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
      Table 10 North America Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
      Table 11 North America Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
      Table 12 North America Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
      Table 13 North America Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
      Table 14 North America Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 15 North America Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
      Table 16 Europe Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
      Table 17 Europe Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
      Table 18 Europe Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
      Table 19 Europe Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
      Table 20 Europe Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
      Table 21 Europe Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 22 Europe Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
      Table 23 Asia Pacific Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
      Table 24 Asia Pacific Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
      Table 25 Asia Pacific Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
      Table 26 Asia Pacific Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
      Table 27 Asia Pacific Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
      Table 28 Asia Pacific Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 29 Asia Pacific Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
      Table 30 Latin America Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
      Table 31 Latin America Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
      Table 32 Latin America Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
      Table 33 Latin America Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
      Table 34 Latin America Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
      Table 35 Latin America Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 36 Latin America Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
      Table 37 The Middle-East and Africa Pharmacovigilance Market, by Country, 2016 – 2026 (USD Million)
      Table 38 The Middle-East and Africa Pharmacovigilance Market, by Service Provider, 2016 – 2026 (USD Million)
      Table 39 The Middle-East and Africa Pharmacovigilance Market, by Product Life Cycle, 2016 – 2026 (USD Million)
      Table 40 The Middle-East and Africa Pharmacovigilance Market, by Type, 2016 – 2026 (USD Million)
      Table 41 The Middle-East and Africa Pharmacovigilance Market, by Process Flow, 2016 – 2026 (USD Million)
      Table 42 The Middle-East and Africa Pharmacovigilance Market, by Therapeutic Area, 2016 – 2026 (USD Million)
      Table 43 The Middle-East and Africa Pharmacovigilance Market, by End user, 2016 – 2026 (USD Million)
      Table 44 Global Pharmacovigilance Market - Company Revenue Analysis, 2016 – 2019 (USD Million)
      Table 45 Global Pharmacovigilance Market - Company Revenue Share Analysis, 2016 – 2019 (%)
      Table 46 Acquisitions and Mergers
      Table 47 Market Drivers – Impact Analysis
      Table 48 Market Restraints
      Table 49 Market Opportunities
      Table 50 Major Buyers of Pharmacovigilance
      Table 51 Distributors/Traders of Pharmacovigilance by Region
      

Industry Major Market Players

  • Wipro Ltd
  • United BioSource Corporation
  • PAREXEL International Corporation
  • TAKE Solutions Ltd.
  • Linical Accelovance
  • ITClinical
  • IQVIA
  • ICON PLC
  • IBM Corporation
  • Foresight Group International AG
  • FMD K&L Inc.
  • Cognizant
  • Capgemini
  • BioClinica
  • ArisGlobal
  • Accenture

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2021 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions